Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy Study of Dysport RU and Glabellar Lines

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 5.0

Eligibility Criteria:
Inclusion Criteria:~* Female between 30 - 60 years of age~* Moderate to severe vertical glabellar lines at maximum frown at baseline~Exclusion Criteria:~* Silicone injections into the upper face~* Any prior treatment with fillers (e.g. collagen-type implants) skin abrasions or photorejuvenation within the previous 12 months~* Any planned facial cosmetic surgery during the study period~* A history of ablative skin resurfacing of the area to be treated during the study.

- Gender: FEMALE
- Minimum Age: 30 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- Dysport RU 20 U (Type: EXPERIMENTAL): None
- Dysport RU 50 U (Type: EXPERIMENTAL): None
- Dysport RU 75 U (Type: EXPERIMENTAL): None
- Dysport (Azzalure) 50 U (Type: ACTIVE_COMPARATOR): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).